NIH Study on the Safety of Receiving a Second Dose of a COVID-19 mRNA Vaccine in Those Who Had an Allergic Reaction to the First Dose

Pamela Guerrerio, MD, PhD, is the principal investigator for a newly launched research study conducted by the National Institutes of Health (NIH). She discusses the research questions being addressed as well as details surrounding inclusion/exclusion criteria and participant involvement.